These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 35248830)

  • 1. Effect of eight-week online cognitive training in Parkinson's disease: A double-blind, randomized, controlled trial.
    van Balkom TD; Berendse HW; van der Werf YD; Twisk JWR; Peeters CFW; Hoogendoorn AW; Hagen RH; Berk T; van den Heuvel OA; Vriend C
    Parkinsonism Relat Disord; 2022 Mar; 96():80-87. PubMed ID: 35248830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COGTIPS: a double-blind randomized active controlled trial protocol to study the effect of home-based, online cognitive training on cognition and brain networks in Parkinson's disease.
    van Balkom TD; Berendse HW; van der Werf YD; Twisk JWR; Zijlstra I; Hagen RH; Berk T; Vriend C; van den Heuvel OA
    BMC Neurol; 2019 Jul; 19(1):179. PubMed ID: 31366395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Memory enhancement by multidomain group cognitive training in patients with Parkinson's disease and mild cognitive impairment: long-term effects of a multicenter randomized controlled trial.
    Schmidt N; Tödt I; Berg D; Schlenstedt C; Folkerts AK; Ophey A; Dimenshteyn K; Elben S; Wojtecki L; Liepelt-Scarfone I; Schulte C; Sulzer P; Eggers C; Kalbe E; Witt K
    J Neurol; 2021 Dec; 268(12):4655-4666. PubMed ID: 33904966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind randomized controlled trial of the efficacy of cognitive training delivered using two different methods in mild cognitive impairment in Parkinson's disease: preliminary report of benefits associated with the use of a computerized tool.
    Bernini S; Panzarasa S; Barbieri M; Sinforiani E; Quaglini S; Tassorelli C; Bottiroli S
    Aging Clin Exp Res; 2021 Jun; 33(6):1567-1575. PubMed ID: 32895890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eight-week multi-domain cognitive training does not impact large-scale resting-state brain networks in Parkinson's disease.
    van Balkom TD; van den Heuvel OA; Berendse HW; van der Werf YD; Vriend C
    Neuroimage Clin; 2022; 33():102952. PubMed ID: 35123203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating a frontostriatal working-memory updating-training paradigm in Parkinson's disease: the iPARK trial, a double-blinded randomized controlled trial.
    Domellöf ME; Walton L; Boraxbekk CJ; Bäckström D; Josefsson M; Forsgren L; Stigsdotter Neely A
    BMC Neurol; 2020 Sep; 20(1):337. PubMed ID: 32894075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erratum.
    Mult Scler; 2016 Oct; 22(12):NP9-NP11. PubMed ID: 26041800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term effects of cognitive training in Parkinson's disease: A randomized, controlled trial.
    van Balkom TD; van den Heuvel OA; Berendse HW; van der Werf YD; Hagen RH; Berk T; Vriend C
    Clin Park Relat Disord; 2023; 9():100204. PubMed ID: 38107671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Parkin'Play study: protocol of a phase II randomized controlled trial to assess the effects of a health game on cognition in Parkinson's disease.
    van de Weijer SC; Duits AA; Bloem BR; Kessels RP; Jansen JF; Köhler S; Tissingh G; Kuijf ML
    BMC Neurol; 2016 Nov; 16(1):209. PubMed ID: 27809791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive rehabilitation for Parkinson’s disease dementia: a study protocol for a pilot randomised controlled trial.
    Hindle JV; Watermeyer TJ; Roberts J; Martyr A; Lloyd-Williams H; Brand A; Gutting P; Hoare Z; Edwards RT; Clare L
    Trials; 2016 Mar; 17():152. PubMed ID: 27000036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Goal management training and psychoeducation / mindfulness for treatment of executive dysfunction in Parkinson's disease: A feasibility pilot trial.
    Giguère-Rancourt A; Plourde M; Racine E; Couture M; Langlois M; Dupré N; Simard M
    PLoS One; 2022; 17(2):e0263108. PubMed ID: 35180229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of repetitive transcranial magnetic stimulation on cognitive impairment in Parkinson's disease with dementia: Pilot study.
    Khedr EM; Mohamed KO; Ali AM; Hasan AM
    Restor Neurol Neurosci; 2020; 38(1):55-66. PubMed ID: 31815705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease.
    Rolinski M; Fox C; Maidment I; McShane R
    Cochrane Database Syst Rev; 2012 Mar; 2012(3):CD006504. PubMed ID: 22419314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Beneficial Effects of Computer-Based Cognitive Training in Parkinson's Disease: A Systematic Review.
    Nousia A; Martzoukou M; Tsouris Z; Siokas V; Aloizou AM; Liampas I; Nasios G; Dardiotis E
    Arch Clin Neuropsychol; 2020 May; 35(4):434-447. PubMed ID: 31942917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy of Cognitive training in patients with VAsCular Cognitive Impairment, No dEmentia (the Cog-VACCINE study): study protocol for a randomized controlled trial.
    Tang Y; Zhu Z; Liu Q; Li F; Yang J; Li F; Xing Y; Jia J
    Trials; 2016 Aug; 17(1):392. PubMed ID: 27496126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computerized cognitive training in Parkinson's disease: A systematic review and meta-analysis.
    Gavelin HM; Domellöf ME; Leung I; Neely AS; Launder NH; Nategh L; Finke C; Lampit A
    Ageing Res Rev; 2022 Sep; 80():101671. PubMed ID: 35714854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of physical exercise programs on cognitive function in Parkinson's disease patients: A systematic review of randomized controlled trials of the last 10 years.
    da Silva FC; Iop RDR; de Oliveira LC; Boll AM; de Alvarenga JGS; Gutierres Filho PJB; de Melo LMAB; Xavier AJ; da Silva R
    PLoS One; 2018; 13(2):e0193113. PubMed ID: 29486000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use, maintenance and dose effects of cognitive speed of processing training in Parkinson's disease.
    Valdés EG; O'Connor ML; Uc EY; Hauser RA; Andel R; Edwards JD
    Int J Neurosci; 2017 Oct; 127(10):841-848. PubMed ID: 27919204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ReSPonD trial--rivastigmine to stabilise gait in Parkinson's disease a phase II, randomised, double blind, placebo controlled trial to evaluate the effect of rivastigmine on gait in patients with Parkinson's disease who have fallen.
    Henderson EJ; Lord SR; Close JC; Lawrence AD; Whone A; Ben-Shlomo Y
    BMC Neurol; 2013 Dec; 13():188. PubMed ID: 24299497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of working memory training in patients with Parkinson's disease without cognitive impairment: A randomized controlled trial.
    Ophey A; Giehl K; Rehberg S; Eggers C; Reker P; van Eimeren T; Kalbe E
    Parkinsonism Relat Disord; 2020 Mar; 72():13-22. PubMed ID: 32078917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.